60 Degrees Pharmaceuticals (SXTP) Stock: Buy, Sell, or Hold?
SXTP - 60 Degrees Pharmaceuticals, Inc. Common Stock
$1.33
0.08 (6.40%)
▲
5d:
+13.68%
30d:
+40.07%
90d:
-20.83%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When SXTP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SXTP is 15.7% above its trading range ($1.15). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SXTP is 15.7% above its trading range ($1.15). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SXTP is currently trading at $1.33, which is considered extended relative to its 30-day fair value range of $0.92 to $1.15.
Technical Outlook: Technically, SXTP is in a strong downtrend. Immediate support is located at $0.92, while resistance sits at $1.39. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: SXTP scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.70 (+196.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SXTP is in a strong downtrend. Immediate support is located at $0.92, while resistance sits at $1.39. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: SXTP scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.70 (+196.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.92 -
$1.15
Company Quality Score
25/100
(STRONG SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+15.7% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.4%)
- BULLISH: Trading 196.0% below Wall St target ($3.70)
- WARNING: Composite score 25/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.92 -
$1.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.39
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.35
Wall Street Target
$3.70
(+196.0%)
Revenue Growth (YoY)
-32.5%
Share & Embed Analysis
Last updated: October 02, 2026 11:33 AM ET
Data refreshes hourly during market hours. Next update: 12:33 PM
Data refreshes hourly during market hours. Next update: 12:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 51 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
